Invention Grant
- Patent Title: Therapeutically active fused pyrimidine derivatives
- Patent Title (中): 治疗活性的融合嘧啶衍生物
-
Application No.: US14239406Application Date: 2012-08-15
-
Publication No.: US09227984B2Publication Date: 2016-01-05
- Inventor: Daniel Christopher Brookings , Daniel James Ford , Anant Ramrao Ghawalkar , Jean Herman , Qiuya Huang , Claire Louise Kulisa , Thierry Louat , Judi Charlotte Neuss , James Thomas Reuberson , Bart Vanderhoydonck
- Applicant: Daniel Christopher Brookings , Daniel James Ford , Anant Ramrao Ghawalkar , Jean Herman , Qiuya Huang , Claire Louise Kulisa , Thierry Louat , Judi Charlotte Neuss , James Thomas Reuberson , Bart Vanderhoydonck
- Applicant Address: BE Brussels BE Leuven
- Assignee: UCB Pharma S.A.,Katholieke Universiteit Leuven, K.U.Leuven R&D
- Current Assignee: UCB Pharma S.A.,Katholieke Universiteit Leuven, K.U.Leuven R&D
- Current Assignee Address: BE Brussels BE Leuven
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: GB1114212.2 20110818
- International Application: PCT/GB2012/051992 WO 20120815
- International Announcement: WO2013/024291 WO 20130221
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519 ; C07D471/00 ; C07D487/00 ; C07D491/00 ; C07D495/04 ; C07D513/04 ; C07D519/00
Abstract:
A series of monocyclic or bicyclic diamine-substituted thieno[2,3-d]pyrimidine and isothiazolo[5,4-d]pyrimidine derivatives are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases; and organ and cell transplant rejection.
Public/Granted literature
- US20140309222A1 Therapeutically Active Fused Pyrimidine Derivatives Public/Granted day:2014-10-16
Information query
IPC分类:
